TRANSLUCENCIA NUCAL AUMENTADA Y CARIOTIPO NORMAL
Antecedentes: La exploración ecográfica entre las semanas 11 y 14 tiene un papel fundamental en el cribado de anomalías cromosómicas, siendo la medida de la translucencia nucal un método bien establecido y ampliamente aceptado para este fin.
Tamara lllescas M +5 more
doaj
--- Objectives --- Prior to foetal karyotyping, the likelihood of Down's syndrome is often determined combining maternal age, serum free beta-HCG, PAPP-A levels and embryonic measurements of crown-rump length and nuchal translucency for gestational ages ...
Bernard Benoit +21 more
core +1 more source
P14.56: Nuchal translucency measurement as screening method for major congenital heart defects in low risk pregnancies [PDF]
C. M. Bilardo +3 more
openalex +1 more source
The Iowa Perinatal Letter, April-May-June 2007, Vol. 28, no.2 [PDF]
This newsletter from The Department of Public Health about perinatal health care and ...
core
OP02.02: Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21 [PDF]
Karl Oliver Kagan +2 more
openalex +1 more source
Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low‐risk population [PDF]
K. Schuchter +4 more
openalex +1 more source
Objective. To assess the effectiveness of atrioventricular valve regurgitation (AVVR) detection using color Doppler in the four-chamber view (4CV) for identifying atrioventricular septal defects (AVSDs) during 11–13 + 6 weeks’ gestation.
Zhen Guo +7 more
doaj +1 more source
0641: Perinatal Outcome in Fetuses with Extremely Large Nuchal Translucency Measurements [PDF]
Fergus Scott +2 more
openalex +1 more source
Nomogram of the anterior cerebral artery doppler indices at 11–13+6 weeks of gestation
Objective To establish nomograms of anterior cerebral artery (ACA) Doppler indices during 11–13+6 weeks of gestation. Methods A descriptive cross-sectional study was conducted on low-risk singleton pregnancies with healthy fetuses.
Ornnat Wanasitchaiwat +4 more
doaj +1 more source
Screening for Down's syndrome by fetal nuchal translucency measurement in a high‐risk population [PDF]
Eva Pajkrt +4 more
openalex +1 more source

